Composition containing monoacetyldiacylglycerol compound as active ingredient for inhibiting blood cancer or metastasis
US10058527B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Aug 18, 2014 |
| Grant date | Aug 28, 2018 |
| Priority date | — |
| Expiry date | Aug 18, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a composition containing a monoacetyldiglyceride compound as an active ingredient, for inhibiting blood cancer or metastasis, and a use thereof. The monoacetyldiglyceride compound according to the present invention has excellent effects of inhibiting the expression of IL-4 and inhibiting the activity of STAT-6, and thereby is capable of overcoming side effects of currently used blood cancer or metastasis inhibiting agents. Also, the monoacetyldiglyceride compound is a non-toxic compound having superior therapeutic effects and thus can be useful as a composition for preventing, treating, or improving blood cancer and metastasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.